Spots Global Cancer Trial Database for Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

Official Title: Randomized Pilot Trial of Omega-3 Fatty Acids or Placebo in Peri- or Post-Menopausal Women at High Risk for Breast Cancer Undergoing a Weight Loss Intervention

Study ID: NCT02101970

Conditions

Breast Cancer

Interventions

Omega-3 Fatty Acids

Placebo Capsule

Diet and Exercise

Study Description

Brief Summary: The purpose of this study is to determine if high dose supplementation with the omega-3 fatty acids EPA and DHA, when added to a weight loss program, is well tolerated in the study population and if there is an increase in the favorable change in blood and tissue breast cancer risk factors when compared to weight loss alone.

Detailed Description: Subjects will all participate in a 6-month weight loss intervention. Subjects will be randomized to receive either blinded placebo or omega-3 fatty acids for 6 months.